MiyeWire, LLC

10/09/2026

Miye and Jack are venturing in Italy this week. How awesome is this picture of them taken in Dolomites? What a backdrop! We hope all our clients have had a great week and have a terrific weekend!!

09/24/2026

A record number of U.S. adults under 35 are living with their parents, according to a recent Realtor.com study.

In 2025, 25.2 million adults under 35 lived at home, a higher share than during the COVID-19 pandemic.

Many are working, but wages are not always keeping up with the cost of living. Among adults ages 25 to 34 who live at home, roughly 7 in 10 have jobs.

Housing affordability is a major factor. Higher home prices, elevated mortgage rates, rent, student loan payments, car payments, and everyday expenses can make living independently harder to sustain.

For some families, moving back home may be a way to reduce expenses, rebuild savings, or create more breathing room before taking the next step.

The broader takeaway is that financial independence does not always follow a straight timeline. Cost-of-living pressures are reshaping what adulthood, housing, and household decisions look like for many families.


Source:

One woman in her mid-30s said her $60,000 annual income wasn't enough to cover all her bills after a breakup, leading her to move back home.

09/23/2026

🐻 Fat Bear Week is back, and the competition is looking VERY well-fed.

From September 22–29, fans can vote for their favorite brown bears at Katmai National Park and Preserve as they pack on the pounds before hibernation. 🐟

This year’s field includes 11 contenders, including reigning champion 32 Chunk, who’s back to defend his title after winning the 2025 crown. 👑

The bracket also features familiar faces like 128 Grazer, 856, 901, 909, and 910, along with several other salmon-fueled heavyweights hoping to become the internet’s next favorite bear.

Fans can watch the bears on Katmai’s live cams and vote through the single-elimination tournament until one gloriously chunky champion remains. 🏆

So, who gets your vote this year? 🐻❤️


Source:

The internet's favorite bear contest is back. See details on Fat Bear Week 2026.

09/10/2026

09/09/2026

⛈️ Severe Weather Prep 🏠

Severe weather season brings wind, rain, and hail. A little prep now goes a long way.

Not sure where to start? Here are a few things worth doing before the next storm rolls through:

🔹 Roof and Gutters: Look for loose shingles and clear out clogs. Small problems get expensive fast once the rain hits.

🔹 Go-Bag: Water, food, flashlight, phone charger, and important documents. Keep it ready so you're not scrambling.

🔹 Know Your Routes: Check your local evacuation routes on a calm day. You'll be glad you did.

🔹 Review Your Coverage: Made home improvements lately? Worth a quick conversation to make sure everything is accounted for.

A little attention now beats a lot of stress later. Reach out anytime if you have questions. 🌟

09/02/2026

🏈 Football season is almost here, and all 32 NFL teams are bringing something new to the field.

From offseason moves and fresh faces to shifting expectations across every division, there’s no shortage of storylines heading into 2026.

The season opens with the New England Patriots facing the Seattle Seahawks in a Super Bowl 60 rematch, and that’s just the beginning.

Whether you’re following your hometown team, setting a fantasy lineup, or just counting down to Sundays on the couch, now’s a great time to catch up on what changed during the offseason.

🏆 Which team are you watching most closely this season?


Source:

NBC Sports has 32 team previews full of stats, storylines and projections that could shape your favorite team’s season.

08/26/2026

A personalized mRNA-based cancer vaccine is showing promise in a late-stage melanoma trial.

Merck and Moderna said the individualized vaccine, paired with the existing immunotherapy Keytruda, significantly reduced the risk of cancer returning or spreading in high-risk melanoma patients whose cancer had been surgically removed.

Earlier Phase 2b data showed a 49% reduction in melanoma recurrence after surgery and a 59% reduction in the cancer spreading to distant organs.

The vaccine is not yet approved by the Food and Drug Administration. Regulators still need to review the full data once it has been collected and submitted.

For now, the results mark another step in the study of mRNA technology for cancer treatment.


Source:

Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among patients with melanoma.